A pilot study of some kinetic aspects of the metabolism of 5-hydroxytryptamine in depressive patients.
D000284:Administration, Oral; D001692:Biological Transport; D001921:Brain / Q000378:metabolism*; D003863:Depression / Q000134:cerebrospinal fluid / Q000175:diagnosis / Q000378:metabolism*; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000134:cerebrospinal fluid*; D007275:Injections, Intravenous; D007408:Intestinal Absorption; D007700:Kinetics; D008297:Male; D011339:Probenecid / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D012701:Serotonin / Q000096:biosynthesis / Q000378:metabolism*; D013129:Spinal Puncture; D013997:Time Factors
D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D011339:Probenecid